The 36-month beta value for ABSI is also noteworthy at 2.07. There are mixed opinions on the stock, with 5 analysts rating it as a “buy,” 4 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for ABSI is 111.47M, and at present, short sellers hold a 22.01% of that float. The average trading volume of ABSI on June 24, 2025 was 3.01M shares.
ABSI) stock’s latest price update
Absci Corp (NASDAQ: ABSI)’s stock price has plunge by 4608723relation to previous closing price of 2.79. Nevertheless, the company has seen a -0.72% plunge in its stock price over the last five trading sessions. globenewswire.com reported 2025-05-20 that VANCOUVER, Wash. and NEW YORK, May 20, 2025 (GLOBE NEWSWIRE) — Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics with generative design, today announced the company will be participating in the following upcoming investor conferences.
ABSI’s Market Performance
ABSI’s stock has fallen by -0.72% in the past week, with a monthly rise of 2.22% and a quarterly drop of -8.31%. The volatility ratio for the week is 2.59% while the volatility levels for the last 30 days are 2.78% for Absci Corp The simple moving average for the last 20 days is -1.78% for ABSI stock, with a simple moving average of -18.97% for the last 200 days.
Analysts’ Opinion of ABSI
Many brokerage firms have already submitted their reports for ABSI stocks, with Needham repeating the rating for ABSI by listing it as a “Buy.” The predicted price for ABSI in the upcoming period, according to Needham is $9 based on the research report published on January 22, 2025 of the current year 2025.
Guggenheim, on the other hand, stated in their research note that they expect to see ABSI reach a price target of $10. The rating they have provided for ABSI stocks is “Buy” according to the report published on October 02nd, 2024.
Morgan Stanley gave a rating of “Overweight” to ABSI, setting the target price at $7 in the report published on July 03rd of the previous year.
ABSI Trading at -4.49% from the 50-Day Moving Average
After a stumble in the market that brought ABSI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -56.40% of loss for the given period.
Stock Fundamentals for ABSI
Current profitability levels for the company are sitting at:
- -23.48 for the present operating margin
- -1.74 for the gross margin
The net margin for Absci Corp stands at -29.56. The total capital return value is set at -0.42. Equity return is now at value -48.98, with -42.37 for asset returns.
Based on Absci Corp (ABSI), the company’s capital structure generated 0.04 points at debt to capital in total, while cash flow to debt ratio is standing at -9.27. The debt to equity ratio resting at 0.04. The interest coverage ratio of the stock is -275.45.
Currently, EBITDA for the company is -89.08 million with net debt to EBITDA at 0.41. When we switch over and look at the enterprise to sales, we see a ratio of 86.17. The receivables turnover for the company is 2.63for trailing twelve months and the total asset turnover is 0.02. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.72.
Conclusion
In summary, Absci Corp (ABSI) has had a mixed performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
